Profiling lipoxygenase metabolism in specific steps of colorectal tumorigenesis

Cancer Prevention Research

Volumn 3, Issue 7, 2010, Pages 829-838

  Shureiqi, Imad ^a,b   Chen, Dongning ^a   Day, R Sue ^c   Zuo, Xiangsheng ^a   Hochman, Fredric Lyone ^d   Ross, William A ^b   Cole, Rhonda A ^e   Moy, Ofie ^a   Morris, Jeffrey S ^b   Xiao, Lianchun ^b   Newman, Robert A ^b   Yang, Peiying ^b   Lippman, Scott M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Department of Gastrointestinal Medical Oncology ^*  (United States)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^d St Luke's Episcopal Hospital   (United States)

^e MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; 13 HYDROXYOCTADECADIENOIC ACID; 15 HYDROXYICOSATETRAENOIC ACID; ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONATE 15 LIPOXYGENASE; ARACHIDONATE 5 LIPOXYGENASE; ICOSANOID; LEUKOTRIENE B4; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER PATIENT; CARCINOGENESIS; COLON BIOPSY; COLORECTAL CANCER; CONTROLLED STUDY; ENZYME METABOLISM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECTUM BIOPSY; RECTUM POLYP; TANDEM MASS SPECTROMETRY;

AGED; AGED, 80 AND OVER; BIOPSY; COLORECTAL NEOPLASMS; FEMALE; GASTRIC MUCOSA; HUMANS; INTERLEUKIN-1BETA; LINOLEIC ACIDS; LIPOXYGENASE; MALE; MIDDLE AGED;

EID: 77954742772     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-09-0110     Document Type: Article

References (42)

1. Brash AR. Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate. J Biol Chem 1999;274:23679-82.
2. Shureiqi I, Lippman SM. Lipoxygenase modulation to reverse carcinogenesis. Cancer Res 2001;61:6307-12.
3. Fürstenberger G, PK K, Müller-Decker AJ, Habenicht R. What are cyclooxygenases and lipoxygenases doing in the driver's seat of carcinogenesis? Int J Cancer 2006;119:2247-54.
4. Pidgeon GP, Lysaght J, Krishnamoorthy S, et al. Lipoxygenase metabolism: roles in tumor progression and survival. Cancer Metastasis Rev 2007;26:503-24.
5. Rigas B, Goldman IS, Levine L. Altered eicosanoid levels in human colon cancer [see comments]. J Lab Clin Med 1993;122:518-23.
6. Shureiqi I, Wojno KJ, Poore JA, et al. Decreased 13-S-hydroxyocta- decadienoic acid levels and 15-lipoxygenase-1 expression in human colon cancers. Carcinogenesis 1999;20:1985-95.
7. Heslin MJ, Hawkins A, Boedefeld W, et al. Tumor-associated down-regulation of 15-lipoxygenase-1 is reversed by celecoxib in colorectal cancer. Ann Surg 2005;241:941-6; discussion 46-7.
8. Watson AJ, Doherty F. Calcium promotes membrane association of reticulocyte 15-lipoxygenase. Biochem J 1994;298:377-83.
9. Shureiqi I, Chen D, Lee JJ, et al. 15-LOX-1: a novel molecular target of nonsteroidal anti-inflammatory drug-induced apoptosis in colorectal cancer cells. J Natl Cancer Inst 2000;92:1136-42.
10. Deguchi A, Xing SW, Shureiqi I, et al. Activation of protein kinase G up-regulates expression of 15-lipoxygenase-1 in human colon cancer cells. Cancer Res 2005;65:8442-7.
11. Kelloff GJ, Lippman SM, Dannenberg AJ, et al. Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer - a plan to move forward. Clin Cancer Res 2006;12:3661-97.
12. Shureiqi I, Wu Y, Chen D, et al. The critical role of 15-lipoxygenase-1 in colorectal epithelial cell terminal differentiation and tumorigenesis. Cancer Res 2005;65:11486-92.
13. Yang P, Chan D, Felix E, et al. Determination of endogenous tissue inflammation profiles by LC-MS/MS: COX- and LOX-derived bioactive lipids. Prostaglandins Leukot Essent Fatty Acids 2006; 75:385-95.
14. O'Donnell VB, Maskrey B, Taylor GW. Eicosanoids: generation and detection in mammalian cells. Methods Mol Biol 2009;462:5-23.
15. Martinez ME, McPherson RS, Levin B, Glober GA. A case-control study of dietary intake and other lifestyle risk factors for hyperplastic polyps. Gastroenterology 1997;113:423-9.
16. Martinez ME, McPherson RS, Levin B, Annegers JF. Aspirin and other nonsteroidal anti-inflammatory drugs and risk of colorectal adenomatous polyps among endoscoped individuals. Cancer Epidemiol Biomarkers Prev 1995;4:703-7.
17. 3. Carcinogenesis 2008;29:790-6.
18. Martinez ME, McPherson RS, Annegers JF, Levin B. Association of diet and colorectal adenomatous polyps: dietary fiber, calcium, and total fat. Epidemiology 1996;7:264-8.
19. Shureiqi I, Zuo X, Broaddus R, et al. The transcription factor GATA-6 is overexpressed in vivo and contributes to silencing 15-LOX-1 in vitro in human colon cancer. Faseb J 2007;21:743-53.
20. Yu J, Marsh S, Ahluwalia R, McLeod HL. Ferredoxin reductase: pharmacogenomic assessment in colorectal cancer. Cancer Res 2003; 63:6170-3.
21. Wu Y, Fang B, Yang XQ, et al. Therapeutic molecular targeting of 15-lipoxygenase-1 in colon cancer. Mol Ther 2008;16:886-92.
22. Willett W, Stampfer MJ. Total energy intake: implications for epidemiologic analyses. Am J Epidemiol 1986;124:17-27.
23. Kamitani H, Taniura S, Ikawa H, Watanabe T, Kelavkar UP, Eling TE. Expression of 15-lipoxygenase-1 is regulated by histone acetylation in human colorectal carcinoma. Carcinogenesis 2001;22: 187-91.
24. Zuo X, Shen L, Issa J-P, et al. 15-Lipoxygenase-1 transcriptional silencing by DNA methyltransferase-1 independently of DNA methylation. FASEB J 2008;22:1981-92.
25. Shureiqi I, Xu X, Chen D, et al. Nonsteroidal anti-inflammatory drugs induce apoptosis in esophageal cancer cells by restoring 15-lipoxygenase-1 expression. Cancer Res 2001;61:4879-84.
26. Shureiqi I, Jiang W, Zuo X, et al. The 15-lipoxygenase-1 product 13-S-hydroxyoctadecadienoic acid down-regulates PPAR-δ to induce apoptosis in colorectal cancer cells. Proc Natl Acad Sci U S A 2003;100:9968-73.
27. Wu J, Xia HH, Tu SP, et al. 15-Lipoxygenase-1 mediates cyclooxygenase-2 inhibitor-induced apoptosis in gastric cancer. Carcinogenesis 2003;24: 243-7.
28. Hsi LC, Xi X, Lotan R, Shureiqi I, Lippman SM. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cells. Cancer Res 2004;64:8778-81.
29. Zuo X, Wu Y, Morris JS, et al. Oxidative metabolism of linoleic acid modulates PPAR-β/δ suppression of PPAR-γ activity. Oncogene 2006;25:1225-41.
30. Nixon JB, Kim KS, Lamb PW, Bottone FG, Eling TE. 15-Lipoxygenase-1 has anti-tumorigenic effects in colorectal cancer. Prostaglandins Leukot Essent Fatty Acids 2004;70:7-15.
31. Yuri M, Sasahira T, Nakai K, Ishimaru S, Ohmori H, Kuniyasu H. Reversal of expression of 15-lipoxygenase-1 to cyclooxygenase-2 is associated with development of colonic cancer. Histopathology 2007;51:520-7.
32. Adam O, Tesche A, Wolfram G. Impact of linoleic acid intake on arachidonic acid formation and eicosanoid biosynthesis in humans. Prostaglandins Leukot Essent Fatty Acids 2008;79:177-81.
33. Craven PA, DeRubertis FR. Profiles of eicosanoid production by superficial and proliferative colonic epithelial cells and sub-epithelial colonic tissue. Prostaglandins 1986;32:387-99.
34. Balkwill F, Charles KA, Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 2005;7:211-7.
35. Clevers H. At the crossroads of inflammation and cancer. Cell 2004; 118:671-4.
36. Ligumsky M, Simon PL, Karmeli F, Rachmilewitz D. Role of interleukin 1 in inflammatory bowel disease-enhanced production during active disease. Gut 1990;31:686-9.
37. Naylor MS, Stamp GW, Balkwill FR. Investigation of cytokine gene expression in human colorectal cancer. Cancer Res 1990;50: 4436-40.
38. Konishi N, Miki C, Yoshida T, Tanaka K, Toiyama Y, Kusunoki M. Interleukin-1 receptor antagonist inhibits the expression of vascular endothelial growth factor in colorectal carcinoma. Oncology 2005; 68:138-45.
39. Jung Y-J, Isaacs JS, Lee S, Trepel J, Neckers L. IL-1β mediated upregulation of HIF-1α via an NFkB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. FASEB J 2003; 03-0329fje.
40. Lu H, Ouyang W, Huang C. Inflammation, a key event in cancer development. Mol Cancer Res 2006;4:221-33.
41. Serhan CN, Jain A, Marleau S, et al. Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators. J Immunol 2003;171: 6856-65.
42. Munger KA, Montero A, Fukunaga M, et al. Transfection of rat kidney with human 15-lipoxygenase suppresses inflammation and preserves function in experimental glomerulonephritis. Proc Natl Acad Sci U S A 1999;96:13375-80.